CoChat
Sign Up
Cited by 859

A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced Death

Saijo, Kaoru, Winner, Beate, Carson, Christian T., Collier, Jana G., Boyer, Leah, Rosenfeld, Michael G., Gage, Fred H., Glass, Christopher K.·2009·Cell
DOI 10.1016/j.cell.2009.01.038PMC PMC2754279
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2009.01.038

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dysregulation of microglia functions contributes to the pathogenesis of neurodegenerative diseases including Alzheimer's disease, Parkinson's disease and Huntington's disease.

    “Dysregulation of microglia functions contribute to the pathogenesis of neurodegenerative diseases, including Alzheimer’s disease (AD) (6–8), Parkinson’s disease (PD) (9–12) and Huntington’s disease (HD) (13–15).”

    From An environment-dependent transcriptional network specifies human microglia identity (2017) · cites this paper as [12]

  • The results are consistent with previous studies on the role of microglia in the development and function of the nervous system.

    “Our results are consistent with previous studies on the role of microglial in the development and function of the nervous system41,48–50.”

    From Identification of a unique TGF-β–dependent molecular and functional signature in microglia (2014) · cites this paper as [49]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 50

  1. Aarnisalo P Kim CH Lee JW Perlmann T 2002 Defining requirements for heterodimerization between the retinoid X receptor and the orphan nuclear receptor Nurr1 J Biol Chem 277 35118 35123 12130634
  2. Akira S Uematsu S Takeuchi O 2006 Pathogen recognition and innate immunity Cell 124 783 801 16497588
  3. Ashburner BP Westerheide SD Baldwin AS Jr 2001 The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression Mol Cell Biol 21 7065 7077 11564889 PMC99882
  4. Atkinson TJ 2008 Toll-like receptors, transduction-effector pathways, and disease diversity: evidence of an immunobiological paradigm explaining all human illness? Int Rev Immunol 27 255 281 18574739
  5. Ballas N Grunseich C Lu DD Speh JC Mandel G 2005 REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis Cell 121 645 657 15907476
  6. Barish GD Downes M Alaynick WA Yu RT Ocampo CB Bookout AL Mangelsdorf DJ Evans RM 2005 A Nuclear Receptor Atlas: macrophage activation Mol Endocrinol 19 2466 2477 16051664
  7. Bonta PI van Tiel CM Vos M Pols TW van Thienen JV Ferreira V Arkenbout EK Seppen J Spek CA van der Poll T 2006 Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses Arterioscler Thromb Vasc Biol 26 2288 2294 16873729
  8. Brown GC 2007 Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase Biochem Soc Trans 35 1119 1121 17956292
  9. Brundin P Li JY Holton JL Lindvall O Revesz T 2008 Research in motion: the enigma of Parkinson’s disease pathology spread Nat Rev Neurosci 9 741 745 18769444
  10. Buss H Dorrie A Schmitz ML Frank R Livingstone M Resch K Kracht M 2004 Phosphorylation of serine 468 by GSK-3β negatively regulates basal p65 NF-κB activity J Biol Chem 279 49571 49574 15465828
  11. Di Virgilio F 2007 Liaisons dangereuses: P2X(7) and the inflammasome Trends Pharmacol Sci 28 465 472 17692395
  12. Doi Y Oki S Ozawa T Hohjoh H Miyake S Yamamura T 2008 Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines Proc Natl Acad Sci U S A 105 8381 8386 18550828 PMC2426110
  13. Farrer MJ 2006 Genetics of Parkinson disease: paradigm shifts and future prospects Nat Rev Genet 7 306 318 16543934
  14. Fearnley JM Lees AJ 1991 Ageing and Parkinson’s disease: substantia nigra regional selectivity Brain 114 Pt 5 2283 2301 1933245
  15. Frank-Cannon TC Tran T Ruhn KA Martinez TN Hong J Marvin M Hartley M Trevino I O’Brien DE Casey B 2008 Parkin deficiency increases vulnerability to inflammation-related nigral degeneration J Neurosci 28 10825 10834 18945890 PMC2603252
  16. Franklin KBJ Paxinos G 2008 The Mouse Brain in Stereotaxic Coordinates 3 Academic Press
  17. Galleguillos D Vecchiola A Fuentealba JA Ojeda V Alvarez K Gomez A Andres ME 2004 PIASγ represses the transcriptional activation induced by the nuclear receptor Nurr1 J Biol Chem 279 2005 2011 14559918
  18. Gao HM Kotzbauer PT Uryu K Leight S Trojanowski JQ Lee VM 2008 Neuroinflammation and oxidation/nitration of α-synuclein linked to dopaminergic neurodegeneration J Neurosci 28 7687 7698 18650345 PMC2702093
  19. Glass CK Ogawa S 2006 Combinatorial roles of nuclear receptors in inflammation and immunity Nat Rev Immunol 6 44 55 16493426
  20. Gundersen HJ Bagger P Bendtsen TF Evans SM Korbo L Marcussen N Moller A Nielsen K Nyengaard JR Pakkenberg B 1988 The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis Apmis 96 857 881 3056461
  21. Hartmann A Hunot S Hirsch EC 2003 Inflammation and dopaminergic neuronal loss in Parkinson’s disease: a complex matter Exp Neurol 184 561 564 14769349
  22. Hay RT 2005 SUMO: a history of modification Mol Cell 18 1 12 15808504
  23. Kanei-Ishii C Ninomiya-Tsuji J Tanikawa J Nomura T Ishitani T Kishida S Kokura K Kurahashi T Ichikawa-Iwata E Kim Y 2004 Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK Genes Dev 18 816 829 15082531 PMC387421
  24. Kawai T Akira S 2007 TLR signaling Semin Immunol 19 24 32 17275323
  25. Kruger R Kuhn W Muller T Woitalla D Graeber M Kosel S Przuntek H Epplen JT Schols L Riess O 1998 Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease Nat Genet 18 106 108 9462735
  26. Le WD Xu P Jankovic J Jiang H Appel SH Smith RG Vassilatis DK 2003 Mutations in NR4A2 associated with familial Parkinson disease Nat Genet 33 85 89 12496759
  27. Lehnardt S Massillon L Follett P Jensen FE Ratan R Rosenberg PA Volpe JJ Vartanian T 2003 Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway Proc Natl Acad Sci U S A 100 8514 8519 12824464 PMC166260
  28. Lehnardt S Schott E Trimbuch T Laubisch D Krueger C Wulczyn G Nitsch R Weber JR 2008 A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS J Neurosci 28 2320 2331 18322079 PMC6671170
  29. Maira M Martens C Philips A Drouin J 1999 Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation Mol Cell Biol 19 7549 7557 10523643 PMC84765
  30. Martin M Rehani K Jope RS Michalek SM 2005 Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3 Nat Immunol 6 777 784 16007092 PMC1933525
  31. Medzhitov R 2007 Recognition of microorganisms and activation of the immune response Nature 449 819 826 17943118
  32. Meredith GE Sonsalla PK Chesselet MF 2008 Animal models of Parkinson’s disease progression Acta Neuropathol 115 385 398 18273623 PMC2562277
  33. Moore DJ West AB Dawson VL Dawson TM 2005 Molecular pathophysiology of Parkinson’s disease Annu Rev Neurosci 28 57 87 16022590
  34. Nagatsu T Sawada M 2005 Inflammatory process in Parkinson’s disease: role for cytokines Curr Pharm Des 11 999 1016 15777250
  35. Nordzell M Aarnisalo P Benoit G Castro DS Perlmann T 2004 Defining an N-terminal activation domain of the orphan nuclear receptor Nurr1 Biochem Biophys Res Commun 313 205 211 14672718
  36. Pascual G Fong AL Ogawa S Gamliel A Li AC Perissi V Rose DW Willson TM Rosenfeld MG Glass CK 2005 A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ Nature 437 759 763 16127449 PMC1464798
  37. Pei L Castrillo A Chen M Hoffmann A Tontonoz P 2005 Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli J Biol Chem 280 29256 29262 15964844
  38. Pei L Castrillo A Tontonoz P 2006 Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77 Mol Endocrinol 20 786 794 16339277
  39. Sakurada K Ohshima-Sakurada M Palmer TD Gage FH 1999 Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain Development 126 4017 4026 10457011
  40. Shi Y Sawada J Sui G Affar el B Whetstine JR Lan F Ogawa H Luke MP Nakatani Y Shi Y 2003 Coordinated histone modifications mediated by a CtBP co-repressor complex Nature 422 735 738 12700765
  41. St-Pierre J Drori S Uldry M Silvaggi JM Rhee J Jager S Handschin C Zheng K Lin J Yang W 2006 Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators Cell 127 397 408 17055439
  42. Tansey MG McCoy MK Frank-Cannon TC 2007 Neuroinflammatory mechanisms in Parkinson’s disease: potential environmental triggers, pathways, and targets for early therapeutic intervention Exp Neurol 208 1 25 17720159 PMC3707134
  43. Teismann P Schulz JB 2004 Cellular pathology of Parkinson’s disease: astrocytes, microglia and inflammation Cell Tissue Res 318 149 161 15338271
  44. Thery C Stanley ER Mallat M 1992 Interleukin 1 and tumor necrosis factor-α stimulate the production of colony-stimulating factor 1 by murine astrocytes J Neurochem 59 1183 1186 1494907
  45. Verstrepen L Bekaert T Chau TL Tavernier J Chariot A Beyaert R 2008 TLR-4, IL-1R and TNF-R signaling to NF-κB: variations on a common theme Cell Mol Life Sci PMC11131687 18535784
  46. Wang X Seed B 2003 A PCR primer bank for quantitative gene expression analysis Nucleic Acids Res 31 e154 14654707 PMC291882
  47. Wang Z Benoit G Liu J Prasad S Aarnisalo P Liu X Xu H Walker NP Perlmann T 2003 Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors Nature 423 555 560 12774125
  48. Whitton PS 2007 Inflammation as a causative factor in the aetiology of Parkinson’s disease Br J Pharmacol 150 963 976 17339843 PMC2013918
  49. Yasuda J Yokoo H Yamada T Kitabayashi I Sekiya T Ichikawa H 2004 Nemo-like kinase suppresses a wide range of transcription factors, including nuclear factor-κB Cancer Sci 95 52 57 14720327 PMC11158368
  50. Zetterstrom RH Solomin L Jansson L Hoffer BJ Olson L Perlmann T 1997 Dopamine neuron agenesis in Nurr1-deficient mice Science 276 248 250 9092472

Cited by

Sorted by citations

Authors
Saijo, K., Winner, B., Carson, C. T., Collier, J. G., Boyer, L., Rosenfeld, M. G., Gage, F. H., & Glass, C. K.
Venue
Cell
Publisher
Elsevier BV
Published
2009-04
Volume
137
Issue
1
Pages
47-59
ISSN
0092-8674
DOI
10.1016/j.cell.2009.01.038
PMC
PMC2754279
Cited by
859
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review